James Callaway
Ph.D., Head of Development
  • Former Senior Executive for AD Immunotherapy Program at Elan (AN-1792).
  • Early-stage clinical trials of BioTherapeutics
  • Secured U.S. and E.U. drug approvals
  • Former President and CEO of Cebix, Inc. and ArmaGen, Inc.
Lon S. Schneider
MD, Medical Director
  • Director, State of CA USC Alzheimer's Disease Center
  • Director, Clinical Core of NIA Alzheimer's Disease Research Center
  • Principal Investigator of CATIE program, a multi-center effectiveness trial of atypical antipsychotics in Alzheimer's disease
Michael Agadjanyan
Ph.D., Sc.D., President
  • Head of the Immunology Dept, Institute for Molecular Medicine, CA
  • 20+ years experience in CNS and 47 years in immunology
  • Serial Entrepreneur: cancer treatment technology, vaccine company, cannabis testing laboratory
Roman Kniazev
Kauffman Fellow, CEO
  • Former Investment director of USD 5+ bln European VC fund, Pharmaceutical department
  • Serial entrepreneur : plasma fractionation technology; anti-allergy nasal spray
Anahit Ghochikyan
PhD, Chief Scientific Officer
  • Institute for Molecular Medicine, CA; University of Nantes, France; Weizmann Institute of Science, Israel
  • 18 years experience in CNS and 30 years in molecular biology and immunology
  • Interests: Immunotherapy of neurodegenerative disorders, antibody-mediated clearance of Aß, tau, α-synuclein, etc
David H. Cribbs
Ph.D, Advisor
  • Professor in Residence, Neurology School of Medicine and Member of MiND Institute at University of California, Irvine
  • Reseach Focus: Age-related factors responsible for the initiation and the progression of Alzheimer’s disease, antibody-mediated clearance of Aß.
Guriq Basi
Ph.D, Advisor
  • Former CSO of Elan Pharmaceuticals (antibody humanization, protein engineering, and protein expression; antibody drugs in CNS indications, review and approval of IND sections)
  • Former SVP of Adverum BioTechnology (gene therapy of ocular indications & rare disease)
Dr. Alexey Dang
  • Former CEO of Cancer Compass (currently is a part of Cancer Treatment Centers of America)
  • Former McKinsey Partner (Silicon Valley office) and Amazon/AWS executive
  • Launched 15+ corporate ventures. Stanford Alumni and a Startup mentor
© 2022 Nuravax